Covidien plc (NYSE: COV) today announced that its Board of Directors has declared a quarterly cash dividend of $0.26 per ordinary share. The dividend is payable on December 27, 2012, to shareholders of record as of the close of business on December 14, 2012. This accelerated quarterly dividend is intended to be in lieu of the quarterly dividend which would have been declared in January 2013. ABOUT COVIDIEN Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2012 revenue of $11.9 billion, Covidien has 43,000 employees worldwide in 70 countries, and its products are sold in over 140 countries. Please visit www.covidien.com to learn more about our business.
Ikaria, which focuses on therapies for critically ill infants, is privately owned by a group led by Madison Dearborn Partners. Buyer Mallinckrodt specializes in diagnostic radiology and pain management.